计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
X421296-1ml |
1ml |
现货 ![]() |
|
英文别名 | 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one,5,11-dihydro-2-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-11-methyl- |
---|---|
规格或纯度 | 10mM in DMSO |
英文名称 | XMD16-5 |
生化机理 | XMD16-5 是一种新型酪氨酸激酶非受体 2(TNK2)抑制剂,对 D163E 和 R806Q 突变的 IC50 值分别为 16 nmol/L 和 77 nmol/L。 |
储存温度 | -80℃储存 |
运输条件 | 超低温冰袋运输 |
产品介绍 |
Information XMD16-5 XMD16-5 is a novel tyrosine kinase nonreceptor 2(TNK2) inhibitor with IC50s of 16 nmol/L and 77 nmol/L for the D163E and R806Q mutations. Targets TNK2 In vitro XMD16-5 is found to be potent in the inhibition of TNK2 phosphorylation. XMD8-87 and XMD16-5 potently inhibit phosphorylation of TNK2 truncation mutations found in solid tumor types. Cell Research(from reference) Cell lines:293T cells Concentrations:10 nM-5 μM Incubation Time:6 h |
ALogP | 2.967 |
---|---|
HBD Count | 3 |
Rotatable Bond | 3 |
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
分子类型 | 未知 |
---|---|
IUPAC Name | 2-[4-(4-hydroxypiperidin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |
INCHI | InChI=1S/C23H24N6O2/c1-28-20-5-3-2-4-18(20)22(31)26-19-14-24-23(27-21(19)28)25-15-6-8-16(9-7-15)29-12-10-17(30)11-13-29/h2-9,14,17,30H,10-13H2,1H3,(H,26,31)(H,24,25,27) |
InChi Key | AGLKBEPKKDHHKY-UHFFFAOYSA-N |
Canonical SMILES | CN1C2=CC=CC=C2C(=O)NC3=CN=C(N=C31)NC4=CC=C(C=C4)N5CCC(CC5)O |
Isomeric SMILES | CN1C2=CC=CC=C2C(=O)NC3=CN=C(N=C31)NC4=CC=C(C=C4)N5CCC(CC5)O |
PubChem CID | 57340666 |
分子量 | 416.48 |
DMSO(mg / mL) Max Solubility | 83 |
---|---|
DMSO(mM) Max Solubility | 199.2892816 |
Water(mg / mL) Max Solubility | <1 |
分子量 | 416.500 g/mol |
XLogP3 | 3.000 |
氢键供体数Hydrogen Bond Donor Count | 3 |
氢键受体数Hydrogen Bond Acceptor Count | 7 |
可旋转键计数Rotatable Bond Count | 3 |
精确质量Exact Mass | 416.196 Da |
单同位素质量Monoisotopic Mass | 416.196 Da |
拓扑极表面积Topological Polar Surface Area | 93.600 Ų |
重原子数Heavy Atom Count | 31 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 619.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Concentration | 9-11(mmol/L) |
---|---|
Proton NMR spectrum | Conforms to Structure |